Comorbidity Burden in a Cohort of Adolescent and Young Adult Patients Diagnosed with Central Nervous System Tumors and Sarcomas.
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Nov 2026 · 1 min read
In brief
In brief
Study examining comorbidity burden in adolescent and young adult patients with CNS tumors and sarcomas, a vulnerable population facing unique challenges from intense multimodal therapy. Understanding comorbidity patterns is critical for tailoring treatment approaches and improving both acute tolerance and long-term survivorship outcomes in this age group.
Written by the GCMD Library team from the article.
Statements in this article
Adolescent and young adult oncology patients experience unique biological, behavioral, and socioeconomic challenges for which provision of care must be tailored.
AYAs with central nervous system tumors and sarcomas represent a vulnerable population with worse outcomes and potential for serious sequelae from intense multimodal therapy.
Comorbidity burden impacts treatment tolerance in adolescent and young adult patients with CNS tumors and sarcomas.